Insider Solutions: Device Database Can Help Pharma - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Insider Solutions: Device Database Can Help Pharma
Standards data is helpful, but FDA needs to apply its information across the board. This article contains bonus online-exclusive material.


Pharmaceutical Technology
Volume 33, Issue 4

Organizations Monitored by the Center for Devices and Radiological Health

AAMI: Association for the Advancement of Medical Instrumentation

ADA: American Dental Association

AIUM: American Institute of Ultrasound in Medicine

ANSI: American National Standards Institute

AOAC: AOAC International

AS: Standards Australia

ASA: Acoustical Society of America

ASME: American Society of Mechanical Engineers

ASQ: American Society for Quality

ASTM: ASTM International

CEN: European Committee for Standardization

CGA: Compressed Gas Associated, Inc.

CLSI: Clinical Laboratory Standards Institute

ESD: Electrostatic Discharge Association

IEC: International Electrotechnical Commission

IEEE: Institute of Electrical and Electronic Engineers

IESNA: Illuminating Engineering Society of North America

ISO: International Organization for Standardization

NCCLS: National Committee for Clinical Laboratory Standards

NEMA: National Electrical Manufacturers Association

NFPA: National Fire Protection Association

RESNA: Rehabilitation Engineering and Assistive Technology of North America

UL: Underwriters Laboratories, Inc.

USP: United States Pharmacopeial Convention, Inc.

Check out the following citations to obtain more information on the agency's participation in standards organizations:

1) OMB Circular A-119 (http://standards.gov/standards_gov/a119.cfm).

2) FDA Policy Statement: Participation in the Development and Use of Voluntary Standards: http://www.fda.gov/oc/guidance/voluntarystandards.html.

3) 21 CFR 10.95 Participation in outside standard-setting activities.

Susan J. Schniepp is vice-president of quality assurance at Javelin Pharmaceuticals, 125 Cambridge Park Drive, Cambridge, MA 02140, tel. 617.499.4709,


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here